XW020D8Introduction of Engineered Allogeneic Thymus Tissue into Muscle, Open Approach, New Technology Group 8

  • Billable / Specific Code
ICD-10-PCS XW020D8
CMS Source: FY 2027 ICD-10-PCS dataset. Effective Oct 1, 2026 – Sep 30, 2027.FacebookXLinkedInPrint

XW020D8 is a billable ICD-10-PCS procedure code for Introduction of Engineered Allogeneic Thymus Tissue into Muscle, Open Approach, New Technology Group 8. It is valid on HIPAA claims for fiscal year 2027 (October 1, 2026 through September 30, 2027) and groups to MS-DRGs 628, 629, 630. The root operation Introduction involves putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products. The Alphabetic Index lists this code under Engineered Allogeneic Thymus Tissue. In AHRQ's Clinical Classifications Software (CCSR), this procedure falls under Administration and transfusion of bone marrow, stem cells, pancreatic islet cells, and t-cells.

Code Identity

ICD-10-PCS Code
XW020D8
Billable Status
Yes — Valid for Submission
Code Describes
Introduction of Engineered Allogeneic Thymus Tissue into Muscle, Open Approach, New Technology Group 8
Short Description
Introduce Enginr Allo Thym Tiss in Muscle, Open, New Tech 8
Parent Code

PCS Table Breakdown

Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.

PositionDesignationValueMeaning
1SectionXNew Technology
2Body SystemWAnatomical Regions
3Operation0Introduction
4BodyPart2Muscle
5Approach0Open
6Device/Substance/TechnologyDEngineered Allogeneic Thymus Tissue
7Qualifier8New Technology Group 8

In the ICD-10-PCS Alphabetic Index

The FY 2027 ICD-10-PCS Alphabetic Index refers to XW020D8 as Engineered Allogeneic Thymus Tissue. These index entries lead to this code:

Direct entry for this code
New Technology, Engineered Allogeneic Thymus Tissue
Direct entry for this code
Leads to this code's table
Anatomy or device term that leads here
Leads to this code's table
Leads to this code's table
Leads to this code's table
Leads to this code's table
Leads to this code's table
Leads to this code's table
Leads to this code's table
Leads to this code's table
Leads to this code's table
Leads to this code's table
Leads to this code's table

To code engineered allogeneic thymus tissue, open the FY 2027 ICD-10-PCS Alphabetic Index at Engineered Allogeneic Thymus Tissue. The entry lists XW020D8 directly as a complete, billable code.

Browse the full ICD-10-PCS Alphabetic Index →

Clinical Classification (CCSR)

AHRQ groups this procedure code into these clinical categories.

ADM011
Administration and transfusion of bone marrow, stem cells, pancreatic islet cells, and t-cells
Clinical domain: Administration of Therapeutic Substances

Code History

Replaces previously assigned code(s):
  • 3E023GC — Introduction of Oth Therap Subst into Muscle, Perc Approach

Similar Procedure Codes

Questions About XW020D8

Is XW020D8 a billable code?

Yes. This is a complete seven-character ICD-10-PCS code, specific enough to report Introduction of Engineered Allogeneic Thymus Tissue into Muscle, Open Approach, New Technology Group 8 on inpatient claims from October 1, 2026 through September 30, 2027.

What is the ICD-10-PCS code for engineered Allogeneic Thymus Tissue?

The ICD-10-PCS Alphabetic Index lists Engineered Allogeneic Thymus Tissue under code XW020D8, Introduction of Engineered Allogeneic Thymus Tissue into Muscle, Open Approach, New Technology Group 8, billable on inpatient claims in fiscal year 2027.

What do the characters in XW020D8 mean?

The code breaks down character by character: the 1st character X is the Section (New Technology); the 2nd character W is the Body System (Anatomical Regions); the 3rd character 0 is the Operation (Introduction); the 4th character 2 is the BodyPart (Muscle); the 5th character 0 is the Approach (Open); the 6th character D is the Device/Substance/Technology (Engineered Allogeneic Thymus Tissue); the 7th character 8 is the Qualifier (New Technology Group 8).

What MS-DRG does XW020D8 group to?

On an inpatient stay, Introduction of Engineered Allogeneic Thymus Tissue into Muscle, Open Approach, New Technology Group 8 maps to MS-DRGs 628, 629, 630, with relative weights from 1.3715 to 3.7023. The MS-DRG sets the fixed Medicare payment for the stay.